StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Europe — Net product revenues by Year

Europe — Net product revenues ($M) ($M)

Vertex Pharmaceuticals Europe — Net product revenues: $3,460M in FY2025, up 0.2% from a year earlier. That is the highest of the 15 years on record here.

Latest, FY2025
3,460
Period ended Dec 31, 2025
Change on a year earlier
+0.2%
3,454 in FY2024
History
15 years
Since FY2011
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Segment & Geographic Information Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEurope — Net product revenues ($M) ($M)Year on yearSource
FY2025Dec 31, 20253,460+0.2%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20243,454+11.1%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20233,109+14.9%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 20222,706+37.1%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 20211,973+75.1%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20201,127+27.2%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 2019886+63.1%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018543+29.2%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 2017420+31.1%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 2016321+45.9%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 2015220+11.1%Form 10-K (filed 2018-02-15) ↗
FY2014Dec 31, 2014198-29.3%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 2013280+115.4%Form 10-K (filed 2014-02-11) ↗
FY2012Dec 31, 2012130+539.4%Form 10-K (filed 2014-02-11) ↗
FY2011Dec 31, 201120.3–Form 10-K (filed 2014-02-11) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Europe — Net product revenues ($M), annual FY2011–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-geo-europe

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.